Filed: 11/14/2025ACC: 0000935836-25-000671
📋 What this filing means
ECOR1 CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $2.08B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$2.08B
Total AUM (reported)
93.71M
Total Shares
Allocation by class
COM$1.40B67.3%
SHS$247.84M11.9%
SHS USD$224.91M10.8%
NAMEN AKT$90.04M4.3%
SPON ADR$57.75M2.8%
COM NEW ADDED$32.69M1.6%
SPONSORED ADS$14.86M0.7%
Portfolio Concentration
Top 3$866.46M41.6%
4–10$813.67M39.0%
11–25$390.97M18.8%
Rest$12.77M0.6%
Top 3 weight
41.6%
Top 10 weight
80.6%
Voting Authority Distribution
Total shares with voting rights: 93.71M
Sole
Full voting authority
93.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
ZYMEWORKS INC
SOLEShares22.97M
TypeSH
Market value$392.33M
18.83%
Sole
22.97M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares7.88M
TypeSH
Market value$241.29M
11.58%
Sole
7.88M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares3.99M
TypeSH
Market value$232.84M
11.17%
Sole
3.99M
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares1.71M
TypeSH
Market value$224.91M
10.79%
Sole
1.71M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares4.29M
TypeSH
Market value$178.60M
8.57%
Sole
4.29M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares1.39M
TypeSH
Market value$90.04M
4.32%
Sole
1.39M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares10.63M
TypeSH
Market value$89.30M
4.29%
Sole
10.63M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$80.74M
3.87%
Sole
6.73M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares3.45M
TypeSH
Market value$78.01M
3.74%
Sole
3.45M
Shared
0.00
None
0.00
XENCOR INC
SOLEShares6.14M
TypeSH
Market value$72.08M
3.46%
Sole
6.14M
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares1.67M
TypeSH
Market value$57.75M
2.77%
Sole
1.67M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares4.08M
TypeSH
Market value$47.77M
2.29%
Sole
4.08M
Shared
0.00
None
0.00
ETON PHARMACEUTICALS INC
SOLEShares2.03M
TypeSH
Market value$44.12M
2.12%
Sole
2.03M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares2.12M
TypeSH
Market value$37.16M
1.78%
Sole
2.12M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares75K
TypeSH
Market value$34.40M
1.65%
Sole
75K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares765K
TypeSH
Market value$33.33M
1.60%
Sole
765K
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares2.82M
TypeSH
Market value$32.69M
1.57%
Sole
2.82M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.27M
TypeSH
Market value$22.03M
1.06%
Sole
1.27M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares500K
TypeSH
Market value$15.00M
0.72%
Sole
500K
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
SOLEShares2.63M
TypeSH
Market value$14.67M
0.70%
Sole
2.63M
Shared
0.00
None
0.00
METSERA INC
SOLEShares271.53K
TypeSH
Market value$14.21M
0.68%
Sole
271.53K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares550K
TypeSH
Market value$13.34M
0.64%
Sole
550K
Shared
0.00
None
0.00
PRIME MEDICINE INC
SOLEShares1.54M
TypeSH
Market value$8.55M
0.41%
Sole
1.54M
Shared
0.00
None
0.00
ATARA BIOTHERAPEUTICS INC
SOLEShares573.18K
TypeSH
Market value$8.21M
0.39%
Sole
573.18K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares872.50K
TypeSH
Market value$7.72M
0.37%
Sole
872.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZYMEWORKS INCSOLE | COM | 22.97M | SH | $392.33M 18.83% | 22.97M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 7.88M | SH | $241.29M 11.58% | 7.88M | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 3.99M | SH | $232.84M 11.17% | 3.99M | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 1.71M | SH | $224.91M 10.79% | 1.71M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 4.29M | SH | $178.60M 8.57% | 4.29M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 1.39M | SH | $90.04M 4.32% | 1.39M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 10.63M | SH | $89.30M 4.29% | 10.63M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $80.74M 3.87% | 6.73M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.45M | SH | $78.01M 3.74% | 3.45M | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 6.14M | SH | $72.08M 3.46% | 6.14M | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 1.67M | SH | $57.75M 2.77% | 1.67M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 4.08M | SH | $47.77M 2.29% | 4.08M | 0.00 | 0.00 |
ETON PHARMACEUTICALS INCSOLE | COM | 2.03M | SH | $44.12M 2.12% | 2.03M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 2.12M | SH | $37.16M 1.78% | 2.12M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 75K | SH | $34.40M 1.65% | 75K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 765K | SH | $33.33M 1.60% | 765K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW ADDED | 2.82M | SH | $32.69M 1.57% | 2.82M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.27M | SH | $22.03M 1.06% | 1.27M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 500K | SH | $15.00M 0.72% | 500K | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCSOLE | COM | 2.63M | SH | $14.67M 0.70% | 2.63M | 0.00 | 0.00 |
METSERA INCSOLE | COM | 271.53K | SH | $14.21M 0.68% | 271.53K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 550K | SH | $13.34M 0.64% | 550K | 0.00 | 0.00 |
PRIME MEDICINE INCSOLE | COM | 1.54M | SH | $8.55M 0.41% | 1.54M | 0.00 | 0.00 |
ATARA BIOTHERAPEUTICS INCSOLE | COM NEW | 573.18K | SH | $8.21M 0.39% | 573.18K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 872.50K | SH | $7.72M 0.37% | 872.50K | 0.00 | 0.00 |
Page 1 of 2